Acute cerebellitis is postulated to result from viral and/or autoimmune etiologies. This disease has been reported to have a variable course. We report a case of sudden death from acute fulminant cerebellitis in a 13-year-old ballet dancer. Serial CT and MRI demonstrated rapid progression of the disease. Histopathologic correlation is provided. The etiologies, clinical course, therapeutic interventions and postmortem evaluation of this potentially life-threatening condition are briefly reviewed.

Keywords:
Cerebellitis, Cerebellar inflammation, Pediatric
1.
Horowitz MB, Pang D, Hirsch W: Acute cerebellitis: Case report and review. Pediatr Neurosurg 1991;17:142–145.
2.
Hayakawa H, Katoh T: Severe cerebellar atrophy following acute cerebellitis. Pediatr Neurol 1995;12:159–161.
3.
Iester A, Alpigiani MG, Franzone G, Cohen A, Puleo MG, Tortori-Donati P: Magnetic resonance imaging in right hemisphere cerebellitis associated with homolateral hemiparesis. Childs Nerv Syst 1995;11:118–120.
4.
Bakshi R, Bates VE, Kinkel PR, Mechtler LL, Kinkel WR: Magnetic resonance imaging findings in acute cerebellitis. Clin Imaging 1998;22:79–85.
5.
Aylett SE, O’Neill KS, De Sousa C, Britton J: Cerebellitis presenting as acute hydrocephalus. Childs Nerv Syst 1998;14:139–141.
6.
Bajada S: Cerebellitis in glandular fever. Med J Aust 1976;1:153–156.
7.
Yoshimoto Y, Koyama S: A case of acquired nystagmus alternans associated with acute cerebellitis. Acta Otolaryngol Suppl 1991;481:371–373.
8.
Gohlich-Ratmann G, Wallot M, Baethmann M, Schaper J, Roggendorf M, Roll C, Aksu F, Voit T: Acute cerebellitis with near-fatal cerebellar swelling and benign outcome under conservative treatment with high dose steroids. Europ J Paediatr Neurol 1998;2:157–162.
9.
Hayase Y, Tobita K: Probable post-influenza cerebellitis. Intern Med 1997;36:747–749.
10.
Neophytides A, Khan S, Louie E: Subacute cerebellitis in Lyme disease. Int J Clin Pract 1997;51:523–524.
11.
Ogata K, Yamada T, Hara H, Taniwaki T, Kira J: An adult case of peripheral facial nerve palsy following acute cerebellitis associated with high antibody titers against varicella-zoster virus (in Japanese). Rinsho Shinkeigaku 1998;38:1070–1072.
12.
Kalyanaraman K, Jagannathan K: Opsoclonus with acute cerebellar ataxia (cerebellitis of pontine encephalitis) of childhood. Neurol India 1971;19:87–91.
13.
Perez CM, Poch VR: Vestibular manifestations in a case of acute post-infectious cerebellitis (in Spanish). An Otorrinolaringol Ibero Am 1980;7:475–491.
14.
Auger C, Van Melkebeek A: Typhoid cerebellitis (observation of a new case) (in French). Bull Soc Med Afr Noire Lang Fr 1973;18:191–192.
15.
Dangond F, Engle E, Yessayan L, Sawyer MH: Pre-eruptive varicella cerebellitis confirmed by PCR. Pediatr Neurol 1993;9:491–493.
16.
Komatsu H, Kuroki S, Shimizu Y, Takada H, Takeuchi Y: Mycoplasma pneumoniae meningoencephalitis and cerebellitis with antiganglioside antibodies. Pediatr Neurol 1998;18:160–164.
17.
Misra GC, Singh SP, Mohapatra MK, Mohapatra RK, Prusty PK, Das RK: Typhoid cerebellitis. J Indian Med Assoc 1985;83:352–353.
18.
Sawaishi Y, Takahashi I, Hirayama Y, Abe T, Mizutani M, Hirai K, Takada G: Acute cerebellitis caused by Coxiella burnetii. Ann Neurol 1999;45:124–127.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.